TNNT2 and cardiovascular disorder: For ACS patients with diabetes, especially those with significantly elevated hs-cTnT levels, it is recommended to enhance postoperative monitoring and management, and optimize secondary prevention measures for cardiovascular diseases, such as intensified antiplatelet therapy, blood glucose control, and lifestyle interventions.